Nanovir, LLC

Kalamazoo, MI 49008

SBIR Award Summary

Total Number of Awards 10
Total Value of Awards $7.69MM
First Award Date 07/01/04
Most Recent Award Date 08/01/12

Key Personnel

Last Name Name Awards Contact
Fisher Christopher Fisher 10

10 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-09-081
Budget: 08/01/12 - 07/31/13

DESCRIPTION (provided by applicant): The proposal seeks support for the pre-clinical development of broad spectrum compounds for treatment of human papillomavirus (HPV). HPV, the most common sexually-transmitted virus, is the cause of cervical dysplasia and cervical cancer. It has also been implicated in several other hyperproliferative diseases...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-09-081
Budget: 08/01/11 - 07/31/12

DESCRIPTION (provided by applicant): The proposal seeks support for the pre-clinical development of broad spectrum compounds for treatment of human papillomavirus (HPV). HPV, the most common sexually-transmitted virus, is the cause of cervical dysplasia and cervical cancer. It has also been implicated in several other hyperproliferative diseases...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-09-081
Budget: 08/01/10 - 07/31/11

DESCRIPTION (provided by applicant): The proposal seeks support for the pre-clinical development of broad spectrum compounds for treatment of human papillomavirus (HPV). HPV, the most common sexually-transmitted virus, is the cause of cervical dysplasia and cervical cancer. It has also been implicated in several other hyperproliferative diseases...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-06-135
Budget: 05/01/10 - 04/30/13

DESCRIPTION (provided by applicant): Human Papillomavirus (HPV) 16 is by far the major cause of cervical dysplasia and cancer, but no effective treatment for the virus is available or anticipated. Major CDC- and/or WHO-authored reviews and surveys of treatments for women infected by HPV16 typically refer to "follow up" observation and surgical i...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-06-135
Budget: 05/01/09 - 04/30/10

DESCRIPTION (provided by applicant): Human Papillomavirus (HPV) 16 is by far the major cause of cervical dysplasia and cancer, but no effective treatment for the virus is available or anticipated. Major CDC- and/or WHO-authored reviews and surveys of treatments for women infected by HPV16 typically refer to "follow up" observation and surgical i...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-06-35
Budget: 05/15/08 - 04/30/09

DESCRIPTION (provided by applicant): Human Papillomavirus (HPV) 16 is by far the major cause of cervical dysplasia and cancer, but no effective treatment for the virus is available or anticipated. Major CDC- and/or WHO-authored reviews and surveys of treatments for women infected by HPV16 typically refer to "follow up" observation and surgical i...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-06-21
Budget: 04/01/08 - 03/31/10

DESCRIPTION (provided by applicant): This project will identify imidazole-pyrrole polyamides to be used as topical antiviral agents for the treatment of human papillomavirus (HPV). Current treatments, which include surgery, freezing, noxious agents, and "biological response modifiers" are primitive or non-specific. We hypothesize that several co...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-06-21
Budget: 04/15/07 - 03/31/08

DESCRIPTION (provided by applicant): This project will identify imidazole-pyrrole polyamides to be used as topical antiviral agents for the treatment of human papillomavirus (HPV). Current treatments, which include surgery, freezing, noxious agents, and "biological response modifiers" are primitive or non-specific. We hypothesize that several co...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-01-52
Budget: 07/01/05 - 06/30/07

This project seeks imidazole-pyrrole polyamides to be used as topical antiviral agents for the treatment of human papillomavirus (HPV). HPV, especially in its sexually-transmitted forms, presents a major public health problem throughout the world. Current treatments, which include surgery, freezing, noxious agents, and =biological response modif...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-01-52
Budget: 07/01/04 - 06/30/05

This project seeks imidazole-pyrrole polyamides to be used as topical antiviral agents for the treatment of human papillomavirus (HPV). HPV, especially in its sexually-transmitted forms, presents a major public health problem throughout the world. Current treatments, which include surgery, freezing, noxious agents, and =biological response modif...

Load More